Revvity Inc. (NYSE:RVTY) Receives Average Recommendation of “Hold” from Brokerages

Revvity Inc. (NYSE:RVTY) has earned a consensus rating of “Hold” from the nineteen research firms that are currently covering the stock, MarketBeat reports. Fourteen equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. The average 1 year price objective among brokerages that have updated their coverage on the stock in the last year is $120.50.

Several research firms recently weighed in on RVTY. Sanford C. Bernstein initiated coverage on Revvity in a research note on Friday, June 26th. They set a “market perform” rating and a $115.00 target price for the company. Evercore reiterated an “outperform” rating on shares of Revvity in a research note on Wednesday, August 5th. KeyCorp raised their target price on shares of Revvity from $125.00 to $165.00 and gave the stock an “overweight” rating in a research report on Friday, September 4th. Barclays lifted their target price on shares of Revvity from $115.00 to $160.00 and gave the company an “equal weight” rating in a report on Wednesday. Finally, Zacks Research upgraded shares of Revvity from a “strong sell” rating to a “hold” rating in a research note on Tuesday, August 4th.

Revvity Stock Performance

NYSE:RVTY opened at $152.28 on Friday. Revvity has a 1-year low of $81.22 and a 1-year high of $166.25. The firm has a market capitalization of $16.99 billion, a price-to-earnings ratio of 72.52, a PEG ratio of 2.79 and a beta of 1.06. The company’s 50-day moving average is $131.65 and its two-hundred day moving average is $110.77. The company has a debt-to-equity ratio of 0.36, a current ratio of 1.80 and a quick ratio of 1.50.

Revvity (NYSE:RVTY) last posted its quarterly earnings data on Tuesday, August 4th. The company reported $1.41 earnings per share for the quarter, topping analysts’ consensus estimates of $1.21 by $0.20. Revvity had a net margin of 8.16% and a return on equity of 8.34%. The firm had revenue of $729.69 million during the quarter, compared to analysts’ expectations of $702.96 million. During the same quarter last year, the company posted $1.18 EPS. The firm’s quarterly revenue was down 1.3% on a year-over-year basis. Revvity has set its FY 2026 guidance at 5.300-5.400 EPS. Analysts forecast that Revvity will post 5.36 EPS for the current year.

Revvity Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, November 13th. Shareholders of record on Friday, October 23rd will be paid a $0.07 dividend. This represents a $0.28 annualized dividend and a dividend yield of 0.2%. The ex-dividend date is Friday, October 23rd. Revvity’s dividend payout ratio (DPR) is 13.33%.

Insider Buying and Selling

In related news, insider Tajinder S. Vohra sold 7,330 shares of the stock in a transaction on Wednesday, September 16th. The stock was sold at an average price of $140.88, for a total transaction of $1,032,650.40. Following the completion of the sale, the insider directly owned 6,635 shares of the company’s stock, valued at $934,738.80. This trade represents a 52.49% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Maxwell Krakowiak sold 1,631 shares of Revvity stock in a transaction on Monday, September 21st. The shares were sold at an average price of $144.53, for a total transaction of $235,728.43. Following the completion of the transaction, the insider owned 14,781 shares in the company, valued at approximately $2,136,297.93. This trade represents a 9.94% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last three months, insiders sold 9,130 shares of company stock worth $1,290,745. Corporate insiders own 0.85% of the company’s stock.

Institutional Trading of Revvity

Hedge funds have recently made changes to their positions in the company. New Mexico Educational Retirement Board raised its stake in shares of Revvity by 1.9% during the 4th quarter. New Mexico Educational Retirement Board now owns 5,416 shares of the company’s stock worth $524,000 after buying an additional 100 shares in the last quarter. Northwestern Mutual Wealth Management Co. lifted its holdings in shares of Revvity by 5.4% in the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 2,074 shares of the company’s stock valued at $231,000 after buying an additional 106 shares during the period. EverSource Wealth Advisors LLC boosted its stake in shares of Revvity by 17.0% in the first quarter. EverSource Wealth Advisors LLC now owns 749 shares of the company’s stock valued at $66,000 after buying an additional 109 shares in the last quarter. Angeles Wealth Management LLC boosted its stake in shares of Revvity by 2.0% in the second quarter. Angeles Wealth Management LLC now owns 5,804 shares of the company’s stock valued at $646,000 after buying an additional 112 shares in the last quarter. Finally, Tema ETFs LLC grew its holdings in Revvity by 8.1% during the second quarter. Tema ETFs LLC now owns 1,946 shares of the company’s stock worth $217,000 after acquiring an additional 145 shares during the period. Institutional investors and hedge funds own 86.65% of the company’s stock.

About Revvity

Revvity, Inc (NYSE:RVTY) is a life sciences and diagnostics company that provides technologies, products and services used in biological research, drug discovery, clinical testing and healthcare. The company serves pharmaceutical and biotechnology companies, academic and government research institutions, hospitals, clinical laboratories and other healthcare organizations.

Its portfolio includes instruments, reagents, consumables, software and related services for areas such as genomics, proteomics, cellular analysis, imaging and multiplex testing.